# Soy Protein in Preventing Recurrent Cancer in Patients Who Have Undergone Surgery for Stage II Prostate Cancer

> **NCT00765479** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Illinois at Chicago** · enrollment: 284 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** soy protein isolate
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00765479
- **Lead sponsor:** University of Illinois at Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2011-09
- **Final completion:** 2013-07
- **Target enrollment:** 284 (ESTIMATED)
- **Last updated:** 2013-09-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00765479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00765479, "Soy Protein in Preventing Recurrent Cancer in Patients Who Have Undergone Surgery for Stage II Prostate Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00765479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*